Pub. Date : 2020 Oct 20
PMID : 32987493
2 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
1 | BACKGROUND: Anlotinib is a newly developed small molecule multiple receptor tyrosine kinase (RTK) inhibitor that was approved for the treatment of patients with lung cancer in China. | anlotinib | ret proto-oncogene | Homo sapiens |
2 | BACKGROUND: Anlotinib is a newly developed small molecule multiple receptor tyrosine kinase (RTK) inhibitor that was approved for the treatment of patients with lung cancer in China. | anlotinib | ret proto-oncogene | Homo sapiens |